COMPANY OVERVIEW

None

---

LOCATION

---

THERAPEUTIC AREAS

---

WEBSITE

None

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

PRESS RELEASES

Sep 20, 2022

Center for Breakthrough Medicines (CBM) and jCyte Announce Strategic Partnership to Manufacture jCyte's Innovative Cell Therapy for Treatment of Retinal Degenerative Diseases USA - English USA - English

Jul 12, 2022

jCyte Announces Appointment of Dr. Stewart Craig as Chief Technology Officer

Nov 15, 2021

jCyte Identifies Key Anatomical Biomarker Predictive of Substantial Restoration of Visual Function in Retinitis Pigmentosa Patients Treated With jCell Therapy

Nov 2, 2021

jCyte Announces Appointment of Peter C. Kuper as Senior Vice President of Finance and Information Technology

Oct 19, 2021

jCyte Announces Appointment of John Pollack, MD, FASRS, as Chief Medical Officer

For More Press Releases

---